| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.007 | 0.8 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | -0.0066 | 0.9 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | -0.007 | 0.9 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.9 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | -0.0062 | 0.9 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.0064 | 0.9 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | -0.0066 | 0.9 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.006 | 0.9 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.0057 | 0.9 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | -0.0086 | 0.9 |